Medifast, Inc. – NYSE:MED
Medifast stock price today
$14.15
-3.45
-19.6%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
Medifast stock price monthly change
-6.73%
month
Medifast stock price quarterly change
-6.73%
quarter
Medifast stock price yearly change
-73.67%
year
Medifast key metrics
Market Cap | 188.37M |
Enterprise value | 129.48M |
P/E | 3.03 |
EV/Sales | 0.14 |
EV/EBITDA | 1.35 |
Price/Sales | 0.22 |
Price/Book | 0.97 |
PEG ratio | 0.19 |
EPS | 6.21 |
Revenue | 897.81M |
EBITDA | 95.33M |
Income | 67.76M |
Revenue Q/Q | -49.92% |
Revenue Y/Y | -41.31% |
Profit margin | 7.55% |
Oper. margin | 9% |
Gross margin | 73.15% |
EBIT margin | 9% |
EBITDA margin | 10.62% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMedifast stock price history
Medifast stock forecast
Medifast financial statements
Average Price Target
$17
Potential upside: 20.14%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 296.18M | 30.28M | 10.22% |
|---|---|---|---|
| Sep 2023 | 235.86M | 23.13M | 9.81% |
| Dec 2023 | 191.01M | 6.03M | 3.16% |
| Mar 2024 | 174.73M | 8.31M | 4.76% |
8.74%
Yield TTM
| Payout ratio | 80.52% |
|---|
| 2019 | 2.74% |
|---|---|
| 2020 | 2.3% |
| 2021 | 2.6% |
| 2022 | 5.55% |
| 2023 | 9.98% |
| Jun 2023 | 318725000 | 133.16M | 41.78% |
|---|---|---|---|
| Sep 2023 | 320019000 | 126.98M | 39.68% |
| Dec 2023 | 309908000 | 108.42M | 34.99% |
| Mar 2024 | 302759000 | 91.79M | 30.32% |
| Jun 2023 | 43.14M | -1.74M | -17.83M |
|---|---|---|---|
| Sep 2023 | 29.93M | -46.45M | -18.15M |
| Dec 2023 | 10.52M | -10.73M | -17.90M |
| Mar 2024 | 7.28M | -2.77M | -1.49M |
Medifast alternative data
| Aug 2023 | 874 |
|---|---|
| Sep 2023 | 874 |
| Oct 2023 | 874 |
| Nov 2023 | 874 |
| Dec 2023 | 874 |
| Jan 2024 | 874 |
| Feb 2024 | 874 |
| Mar 2024 | 634 |
| Apr 2024 | 634 |
| May 2024 | 634 |
| Jun 2024 | 634 |
| Jul 2024 | 634 |
Medifast other data
76.20%
-5.97%
of MED is owned by hedge funds
226
-44
8.71M
-849.48K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2023 | 617 | 0 |
| Mar 2023 | 0 | 2200 |
| May 2023 | 830 | 0 |
| Aug 2023 | 882 | 38316 |
| Oct 2023 | 0 | 5613 |
| Nov 2023 | 353 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | THOMAS ANDREA B director | Common Stock | 50 | $68.89 | $3,445 | ||
Purchase | HOER MICHAEL A. director | Common Stock | 49 | $68.89 | $3,376 | ||
Purchase | SCHLACKMAN SCOTT director | Common Stock | 52 | $68.89 | $3,582 | ||
Purchase | BROWN JEFFREY J director | Common Stock | 58 | $68.89 | $3,996 | ||
Purchase | BROWN JEFFREY J director | Common Stock | 58 | $68.89 | $3,996 | ||
Purchase | XIAN MING director | Restricted Stock Units (cash settled) | 48 | N/A | N/A | ||
Purchase | BROWN JEFFREY J director | Common Stock | 96 | $70.55 | $6,773 | ||
Purchase | BROWN JEFFREY J director | Common Stock | 96 | $70.55 | $6,773 | ||
Sale | HALLQUIST CONSTANCE J. | Common Stock | 5,613 | $73.87 | $414,632 | ||
Sale | BROWN JEFFREY J director | Common Stock | 9,832 | $89.79 | $882,815 |
| Quarter | Transcript |
|---|---|
| Q1 2024 29 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 20 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 6 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Daniel R. Chard (1965) Executive Chairman & Chief Executive Officer | $2,680,000 |
Mr. Anthony E. Tyree (1966) Chief Marketing Officer | $893,800 |
Mr. Nicholas M. Johnson (1980) Pres of Coach & Client Experience | $861,940 |
Mr. William M. Baker IV (1972) Executive Vice President of Information Technology | $729,770 |
Mr. James P. Maloney CPA (1968) Chief Financial Officer | $694,620 |
WW International: Menopause Health's Comeback
Medifast: Coach Surge Fuels Growth
LifeMD: A GLP-1 Play With A Kicker
Walmart: Ozempic And Its Potential Impact On Grocery Sales
Medifast: Take Advantage Of Pessimism Over Weight Loss Drugs
In The Murky MLM Space, Medifast Might Actually Hold Some Promise
Medifast: A High Yield But Low Portfolio Size Hold For Me
Medifast: A Low Earnings Multiple Despite Strong Financial Performance
Medifast Stock Shows Promise At Current Valuation
-
What's the price of Medifast stock today?
One share of Medifast stock can currently be purchased for approximately $14.15.
-
When is Medifast's next earnings date?
Unfortunately, Medifast's (MED) next earnings date is currently unknown.
-
Does Medifast pay dividends?
Yes, Medifast pays dividends and its trailing 12-month yield is 8.74% with 81% payout ratio. The last Medifast stock dividend of $1.42 was paid on 8 Feb 2022.
-
How much money does Medifast make?
Medifast has a market capitalization of 188.37M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 32.94% to 1.07B US dollars.
-
What is Medifast's stock symbol?
Medifast, Inc. is traded on the NYSE under the ticker symbol "MED".
-
What is Medifast's primary industry?
Company operates in the Consumer Cyclical sector and Personal Products & Services industry.
-
How do i buy shares of Medifast?
Shares of Medifast can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Medifast's key executives?
Medifast's management team includes the following people:
- Mr. Daniel R. Chard Executive Chairman & Chief Executive Officer(age: 60, pay: $2,680,000)
- Mr. Anthony E. Tyree Chief Marketing Officer(age: 59, pay: $893,800)
- Mr. Nicholas M. Johnson Pres of Coach & Client Experience(age: 45, pay: $861,940)
- Mr. William M. Baker IV Executive Vice President of Information Technology(age: 53, pay: $729,770)
- Mr. James P. Maloney CPA Chief Financial Officer(age: 57, pay: $694,620)
-
How many employees does Medifast have?
As Jul 2024, Medifast employs 634 workers.
-
When Medifast went public?
Medifast, Inc. is publicly traded company for more then 31 years since IPO on 30 Dec 1993.
-
What is Medifast's official website?
The official website for Medifast is medifastinc.com.
-
Where are Medifast's headquarters?
Medifast is headquartered at 100 International Drive, Baltimore, MD.
-
How can i contact Medifast?
Medifast's mailing address is 100 International Drive, Baltimore, MD and company can be reached via phone at +41 05818042.
-
What is Medifast stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Medifast in the last 12 months, the avarage price target is $17. The average price target represents a 20.14% change from the last price of $14.15.
Medifast company profile:
Medifast, Inc.
medifastinc.comExchange:
NYSE
Full time employees:
634
Industry:
Personal Products & Services
Sector:
Consumer Cyclical
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
100 International Drive
Baltimore, MD 21202
Baltimore, MD 21202
CIK: 0000910329
ISIN: US58470H1014
CUSIP: 58470H101
